2,5-Diketopiperazine Derivatives as Potential Anti-Influenza (H5N2) Agents: Synthesis, Biological Evaluation, and Molecular Docking Study

Molecules. 2022 Jun 29;27(13):4200. doi: 10.3390/molecules27134200.

Abstract

2,5-Diketopiperazine derivatives, consisting of benzylidene and alkylidene substituents at 3 and 6 positions, have been considered as a core structure for their antiviral activities. Herein, the novel N-substituted 2,5-Diketopiperazine derivatives were successfully prepared and their antiviral activities against influenza virus were evaluated by monitoring viral propagation in embryonated chicken eggs. It was found that (3Z,6Z)-3-benzylidene-6-(2-methyl propylidene)-4-substituted-2,5-Diketopiperazines (13b-d), (3Z,6E)-3-benzylidene-6-(2-methylpropyli dene)-1-(1-ethyl pyrrolidine)-2,5-Diketopiperazine (14c), and Lansai-C exhibited negative results in influenza virus propagation at a concentration of 25 µg/mL. Additionally, molecular docking study revealed that 13b-d and 14c bound in 430-cavity of neuraminidase from H5N2 avian influenza virus and the synthesized derivatives also strongly interacted with the key amino acid residues, including Arg371, Pro326, Ile427, and Thr439.

Keywords: 2,5-Diketopiperazines; Lansai C; Lansai D; antiviral activity; influenza virus; molecular docking.

MeSH terms

  • Animals
  • Antiviral Agents / chemistry
  • Diketopiperazines / pharmacology
  • Humans
  • Influenza A Virus, H5N2 Subtype*
  • Influenza, Human*
  • Molecular Docking Simulation
  • Molecular Structure
  • Neuraminidase / chemistry

Substances

  • Antiviral Agents
  • Diketopiperazines
  • 2,5-dioxopiperazine
  • Neuraminidase

Grants and funding

This research received no external funding.